SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-008521
Filing Date
2024-03-19
Accepted
2024-03-19 16:16:09
Documents
16
Period of Report
2024-03-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20240318_8k.htm   iXBRL 8-K 32435
2 EXHIBIT 99.1 ex_641410.htm EX-99.1 182616
7 logo01.jpg GRAPHIC 18167
  Complete submission text file 0001437749-24-008521.txt   386200

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dmac-20240319.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20240319_def.xml EX-101.DEF 11029
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20240319_lab.xml EX-101.LAB 14742
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20240319_pre.xml EX-101.PRE 11134
20 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20240318_8k_htm.xml XML 2731
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 24763444
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)